Noninvasive scans of retinal thickness and vasculature may be used in risk assessment for cognitive dysfunction for adults with type 1 diabetes, according to study data.
“Currently, methods for detecting cognitive disorders, such as MRI and PET scans, are time-consuming, not widely available and expensive,” Ward Fickweiler, MD, a research fellow in the department of ophthalmology at Harvard Medical School, and George L. King, MD, a professor of medicine and ophthalmology at Harvard Medical School and chief scientific officer at Joslin Diabetes Center, told Healio. “Routine
Uncategorized